Baseline | DTG+RPV (N = 513) | CAR (N = 511) | |||||
---|---|---|---|---|---|---|---|
TND | TD | 40 to 50c/mL | TND | TD | 40 to 50c/mL | ||
399 (78%) | 98 (19%) | 12 (2%) | 422 (83%) | 76 (15%) | 11 (2%) | ||
Post‐baseline | ≥50c/mLa | 21 (5%) | 14 (14%) | 4 (33%) | 22 (5%) | 13 (17%) | 2 (18%) |
40 ≤ VL50c/mLa | 12 (3%) | 4 (4%) | 2 (17%) | 5 (1%) | 6 (8%) | 1 (9%) | |
VL40c/mL & TDa | 177 (44%) | 61 (62%) | 4 (33%) | 172 (41%) | 43 (57%) | 7 (64%) | |
VL40c/mL & TNDb | 189 (47%) | 19 (19%) | 2 (17%) | 223 (53%) | 14 (18%) | 1 (9%) |
Post‐baseline categories are mutually exclusive, with categories on the top to take precedence (categories further up indicate worst baseline VL state). Four participants in DTG+RPV and two in CAR had no post‐baseline viral load data and thus are not included at baseline. ain at least one time point after baseline through Week 48. bin all time points post‐baseline.